PIQUR was incorporated in August 2011 as a spin-off of the Basel University. PIQUR is a targeted cancer therapy start-up company focused on the discovery and the development of innovative anti-cancer drugs. PIQUR is embedded in a huge and very experienced network in Basel and internationally. The exceptional location at the Rosental campus enables an exchange between different biotech companies and builds a unique cluster of young, talented and experienced researchers in the field of oncology. PIQUR is enjoying unique support by its hosting University of Basel, both in terms of IP funding and the use of laboratories and labour.